Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

GPCR

Structure Therapeutics (GPCR)

Structure Therapeutics Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:GPCR
FechaHoraFuenteTítuloSímboloCompañía
09/05/202415:56Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:GPCRStructure Therapeutics Inc
09/05/202415:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GPCRStructure Therapeutics Inc
09/05/202415:05GlobeNewswire Inc.Structure Therapeutics Reports First Quarter 2024 Financial Results and Recent HighlightsNASDAQ:GPCRStructure Therapeutics Inc
08/03/202415:19Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:GPCRStructure Therapeutics Inc
08/03/202415:05GlobeNewswire Inc.Structure Therapeutics to Present at Leerink Partners Global Biopharma ConferenceNASDAQ:GPCRStructure Therapeutics Inc
08/03/202408:19Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:GPCRStructure Therapeutics Inc
08/03/202407:30GlobeNewswire Inc.Structure Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent HighlightsNASDAQ:GPCRStructure Therapeutics Inc
18/12/202306:30GlobeNewswire Inc.Structure Therapeutics Provides Comprehensive GSBR-1290 Program Update Including Clinically Meaningful Proof-of-Concept Data From Phase 2a Clinical StudyNASDAQ:GPCRStructure Therapeutics Inc
29/11/202323:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:GPCRStructure Therapeutics Inc
17/11/202316:25Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:GPCRStructure Therapeutics Inc
17/11/202315:51Edgar (US Regulatory)Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]NASDAQ:GPCRStructure Therapeutics Inc
14/11/202315:10GlobeNewswire Inc.Structure Therapeutics Reports Third Quarter 2023 Financial Results and Recent HighlightsNASDAQ:GPCRStructure Therapeutics Inc
29/09/202306:32GlobeNewswire Inc.Structure Therapeutics Announces $300 Million Private Placement Equity FinancingNASDAQ:GPCRStructure Therapeutics Inc
29/09/202306:30GlobeNewswire Inc.Structure Therapeutics Announces Positive Results from Phase 1b Clinical Study of Oral GLP-1 Receptor Agonist GSBR-1290 and Provides Program UpdateNASDAQ:GPCRStructure Therapeutics Inc
10/08/202315:05GlobeNewswire Inc.Structure Therapeutics Reports Second Quarter 2023 Financial Results and Recent HighlightsNASDAQ:GPCRStructure Therapeutics Inc
03/08/202316:32GlobeNewswire Inc.Structure Therapeutics Appoints Ted W. Love, M.D., to Board of DirectorsNASDAQ:GPCRStructure Therapeutics Inc
07/06/202307:30GlobeNewswire Inc.Structure Therapeutics Announces Poster Presentations of its Oral GLP-1 Receptor Agonist GSBR-1290 at the American Diabetes Association 83rd Scientific SessionsNASDAQ:GPCRStructure Therapeutics Inc
05/06/202315:06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GPCRStructure Therapeutics Inc
31/05/202315:30GlobeNewswire Inc.Structure Therapeutics to Present at Jefferies Healthcare ConferenceNASDAQ:GPCRStructure Therapeutics Inc
25/05/202315:30GlobeNewswire Inc.Structure Therapeutics Initiates Phase 2a Study of Oral GLP-1 agonist GSBR-1290 for the Treatment of Type 2 Diabetes and ObesityNASDAQ:GPCRStructure Therapeutics Inc
18/05/202315:30GlobeNewswire Inc.Structure Therapeutics Announces Poster Presentations at the American Thoracic Society International ConferenceNASDAQ:GPCRStructure Therapeutics Inc
11/05/202316:01Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:GPCRStructure Therapeutics Inc
11/05/202315:30GlobeNewswire Inc.Structure Therapeutics Reports First Quarter 2023 Financial Results and Recent HighlightsNASDAQ:GPCRStructure Therapeutics Inc
30/03/202316:16Edgar (US Regulatory)Annual Report (10-k)NASDAQ:GPCRStructure Therapeutics Inc
30/03/202315:30GlobeNewswire Inc.Structure Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Recent HighlightsNASDAQ:GPCRStructure Therapeutics Inc
13/02/202316:29Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:GPCRStructure Therapeutics Inc
07/02/202315:00GlobeNewswire Inc.Structure Therapeutics Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional American Depositary SharesNASDAQ:GPCRStructure Therapeutics Inc
03/02/202323:15PR Newswire (US)Qiming Venture Partners Backed Structure Therapeutics Successfully Debuts on NasdaqNASDAQ:GPCRStructure Therapeutics Inc
02/02/202318:41GlobeNewswire Inc.Structure Therapeutics Announces Pricing of Upsized Initial Public OfferingNASDAQ:GPCRStructure Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:GPCR

Su Consulta Reciente

Delayed Upgrade Clock